Infusion pump systems and methods

• US 10,576,204 B2
• Filed: 09/25/2017
• Issued: 03/03/2020
• Est. Priority Date: 03/16/2011
• Status: Active Grant

• Current Assignee: Insulet Corporation
• Original Assignee: Bigfoot Biomedical, Inc.
• Inventors: Estes, Mark C., Qi, Wenkang, Hopper, Phillip
• Primary Examiner(s): Schmidt, Emily L
• Application Number:
  US15/714,084
• Publication Number:
  US 20180085522A1
• Time in Patent Office: 890 Days
• CPC Class Codes: A61M 2205/35 Communication
• CPC Class Codes: A61M 2205/3569 sublocal, e.g. between console and disposable
• CPC Class Codes: A61M 2205/3592 using telemetric means, e.g. radio or optical transmission
• CPC Class Codes: A61M 2230/201 Glucose concentration
• CPC Class Codes: A61M 5/1413 Modular systems comprising interconnecting elements
• CPC Class Codes: A61M 5/14244 adapted to be carried by the patient, e.g. portable on the body
• CPC Class Codes: A61M 5/168 Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body flow control in general G05D7/00
• CPC Class Codes: A61M 5/172 electrical or electronic A61M5/16804, A61M5/16831 take precedence
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: F04B 17/03 driven by electric motors
• CPC Class Codes: F04B 19/22 of reciprocating-piston type
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/63 for local operation

Abstract

Some embodiments of an infusion pump system can include a controller in which one or more features sets to be provided by the controller are enabled or disabled based upon the particular pump device that is connected to the controller. For example, in some embodiments, one or more advanced features of the controller are available to the user only when a first type of pump device (e.g., having predefined settings stored therein) is connected to the controller, and those advanced features of the controller are disabled when a second type of pump device is connected to the controller.

Claims

1. An insulin delivery system, comprising:

at least a first disposable insulin delivery device and at least a second disposable insulin delivery device, wherein each of the first and second disposable insulin delivery devices each comprise;

a fluid cartridge comprising a plunger at a first end of the fluid cartridge, a septum at the second end of the fluid cartridge, and insulin medication,

a housing that defines a space to receive the fluid cartridge, and

a drive system configured to dispense the insulin medicine from the insulin delivery device,

wherein the first disposable insulin delivery device is of a different type than the second disposable insulin delivery device, wherein the insulin medication in the first disposable insulin delivery device is different from the insulin medication in the second disposable insulin delivery device;

a body-worn glucose monitoring device; and

a controller device removably attachable to each of the first and second insulin delivery devices, the controller device being adapted to determine the type of a disposable insulin delivery device secured to the controller device, the controller device comprising a user interface display, wherein the controller device is configured to automatically enable wireless communication with the body-worn glucose monitoring device in response to the controller device being connected to the first disposable insulin delivery device and to disable wireless communication with the body-worn glucose monitoring device in response to the controller being connected to the second disposable insulin delivery device, wherein the controller device is configured to display a user'"'"'s glucose level when data from the body-worn glucose monitoring device is wirelessly received by the controller device when wireless communication with the body-worn glucose monitoring device is enabled, wherein the controller device is enabled to provide customized insulin delivery options for each of the first and second disposable insulin delivery devices tailored to the pharmakinetic characteristics of the insulin medication in each disposable insulin delivery device, wherein the controller device is configured to notify the user of the type of medication in the disposable insulin delivery device reversibly attached to the controller device when the controller device is reversibly attached to the disposable insulin delivery device.

2. The system of claim 1, wherein the first disposable insulin delivery device and the second disposable insulin delivery device are insulin pump devices.

3. The system of claim 2, wherein the controller device forms an electrical connection with one of the insulin pump devices reversibly connected to the controller device.

4. The system of claim 3, wherein the controller device reads a therapy parameter from the insulin pump device connected to the controller device.

5. The system of claim 1, wherein the insulin pump devices each comprise a battery.

6. The system of claim 1, wherein the controller device forms an electrical connection to each disposable insulin delivery device when reversibly attached thereto.

7. The system of claim 6, wherein each disposable insulin delivery device comprises a means for indicating the type of disposable insulin delivery device, the indicating means being recognizable by the controller device in response to the electrical connection.